Prescription monitoring of anti-hypertensive drug utilisation at the Panjab University Health Centre in India

Singapore Medical Journal

Volumn 45, Issue 3, 2004, Pages 117-120

  Tiwari, H ^a   Kumar, A ^a   Kulkarni, S K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Anti hypertensive drugs; Drug utilisation; Hypertension; Prescribing pattern; Prescription monitoring

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BENZTHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; INDAPAMIDE; NIFEDIPINE; RAMIPRIL; TRIAMTERENE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; DRUG UTILIZATION; FEMALE; HUMAN; HYPERTENSION; INDIA; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL PRACTICE; MONOTHERAPY; OUTPATIENT; PILOT STUDY; PRESCRIPTION; WORLD HEALTH ORGANIZATION;

ANTIHYPERTENSIVE AGENTS; DRUG THERAPY, COMBINATION; DRUG UTILIZATION REVIEW; FEMALE; GUIDELINE ADHERENCE; HUMANS; HYPERTENSION; INDIA; MALE; PHYSICIAN'S PRACTICE PATTERNS; PILOT PROJECTS; UNIVERSITIES;

EID: 3342899415     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trial in their epidemiological context. Lancet 1990; 335:827-38.
2. Hansson L. The benefits of lowering elevated blood pressure: a critical review of studies of cardiovascular morbidity and mortality in hypertension. J Hypertens 1996; 14:537-44.
3. Hansson L, Dahlof B, Gudbrandsson T, Hellsing T, Kullman S, Kuylenstierna J, et al. Antihypertensive effect of felodipine or hydralazine when added to beta-blocker therapy. J Cardiovasc Pharmacol 1988; 12:94-101.
4. Kjeldsen SE, Farsang C, Sleigh P, Mancia G. World Health Organization: International Society of Hypertension. 1999 WHO/ISH hypertension guidelines-highlights and esh update. J Hypertens 2001; 19:2285-8.
5. Ramsay LE. British Hypertension Society Guideline for hypertension management: summary. Br Med J 1999; 319:630-5.
6. Kapoor B, Raina RK, Kapoor S. Drug prescribing pattern in a teaching hospital. Ind J Pharmacol 1985; 17 Suppl 1:168.
7. Pradhan SC, Shewade DG, Shashindrap CH, Bappa JS. Drug utilization studies. National Med J India 1988; 1:185.
8. Bimo, Chowdhary A, Das A, Diwan V, Kafle KK, Mabadeje B, et al. In: How to investigate drug use in health facilities (selected drug use indicator) action programme on essential drugs. WHO official publication. 1995:68.
9. Yuen YH, Chang S, Chong CK, Lee SC, Critchlev JA, Chan JC. Drug utilization in a hospital general medical outpatient clinic with particular reference to antihypertensive and antidiabetic drugs. J Clin Pharm Ther 1998; 23:287-94.
10. Mancia G, Grassi G. Antihypertensive treatment: past, present and future. J Hypertens 1998; 16:S1-7.
11. Prisant LM, Beall SP, Nicholads GE, Feldman EB, Carr AA, Feldman DS, et al. Biochemical, endocrine, and mineral effects of indapamide in black women. J Clin Pharmacol 1990; 30:121-6.
12. Hansson L. The place of beta-blockers in the treatment of hypertension in 1993. Clin Exp Hypertens 1993; 15:1257-62.
13. Chalmers J. The place of combination therapy in the treatment of hypertension in 1993. Clin Exp Hypertens 1993; 15:1299-313.
14. Alkhaja KA, Sequeira RP, Damanhori AH, Mathur VS. Autihypertensive drug-associated sexual dysfunction: a prescription analysis-based study. Pharmacoepidemiol Drug Saf 2003; 12:203-12.
15. Dahlof B, Hosie J. Antihypertensive efficacy and tolerability of a fixed combination of metoprolol and felodipine in comparison with the individual substances in monotherapy. The Swedish/United Kingdom Study Group. J Cardiovasc Pharmacol 1990; 16:910-6.
16. Overlack A, Ruppert M, Kolloch R, Kraft K, Stumpe KO. Age is a major determinant of the divergent blood pressure responses to varying salt intake in essential hypertension. Am J Hypertens 1995; 8:829-36.
17. Carre A. Pharmacologic importance of the combination atenolol/nifedipine in hypertensive patients. Drugs 1998; 56 Suppl 2:23-30.